Cargando…
Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
The growth rate of the MAC16 tumour in cachectic animals was significantly enhanced by the hypolipidemic agent bezafibrate, while the growth rate of a histologically similar tumour, the MAC13, which grows without an effect on host body compartments was unaffected. Growth of the MAC16 in vitro was un...
Autores principales: | Mulligan, H. D., Tisdale, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977866/ https://www.ncbi.nlm.nih.gov/pubmed/1764364 |
Ejemplares similares
-
Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo
por: Russell, S T, et al.
Publicado: (2002) -
Metabolic effects of bezafibrate in mitochondrial disease
por: Steele, Hannah, et al.
Publicado: (2020) -
Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017) -
Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012) -
Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
por: Teramoto, Tamio, et al.
Publicado: (2012)